Literature DB >> 7868229

Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.

M E Wilson1, P M Bronson, R G Hamilton.   

Abstract

Sera from patients with localized juvenile periodontitis (LJP) often contain markedly elevated levels of immunoglobulin G2 (IgG2) antibodies reactive to cell envelope constituents of Actinobacillus actinomycetemcomitans. The objective of this study was to determine if these IgG2 antibodies are capable of supporting phagocytosis and killing of A. actinomycetemcomitans by human neutrophils. Polyclonal IgG2 antibodies were prepared from high-titer LJP serum by affinity chromatography, yielding a preparation which was > 99% subclass restricted and retained immunoreactivity to A. actinomycetemcomitans antigens. Affinity-purified IgG2 antibodies were evaluated by an in vitro opsonophagocytic assay that employed neutrophils obtained from donors who were homozygous for the H131 allotype of Fc gamma receptor type IIa (CD32), which efficiently binds human IgG2 antibodies. Affinity-purified IgG2 antibodies from LJP serum but not from sera of periodontally healthy individuals promoted phagocytosis and killing of A. actinomycetemcomitans. The expression of IgG2-dependent opsonic activity required the presence of complement. Incubation of A. actinomycetemcomitans with neutrophils in the presence of an optimal concentration of LJP IgG2 (50 micrograms/ml) and 5% hypogammaglobulinemic serum (as a complement source) resulted in a > 1 log10 reduction in bacterial viability within 30 min. The opsonic activity of IgG2 antibodies was found to be comparable to that observed with affinity-purified IgG1 antibodies. Moreover, IgG1 antibodies interacted synergistically with IgG2 antibodies in promoting opsonophagocytosis of A. actinomycetemcomitans. The results of this study indicate that LJP serum contains IgG2 antibodies which, when employed in conjunction with neutrophils that express Fc gamma receptors capable of recognizing this subclass, are opsonic for A. actinomycetemcomitans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868229      PMCID: PMC173111          DOI: 10.1128/iai.63.3.1070-1075.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae.

Authors:  J M Musser; J S Kroll; D M Granoff; E R Moxon; B R Brodeur; J Campos; H Dabernat; W Frederiksen; J Hamel; G Hammond
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

2.  Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  P J Baker; M E Wilson
Journal:  Oral Microbiol Immunol       Date:  1989-06

3.  Monoclonal antibody-based immunoenzymetric assays for quantification of human IgG and its four subclasses.

Authors:  R G Hamilton; R W Wilson; T Spillman; M Roebber
Journal:  J Immunoassay       Date:  1988

Review 4.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis.

Authors:  H Watanabe; P D Marsh; L Ivanyi
Journal:  Arch Oral Biol       Date:  1989       Impact factor: 2.633

6.  Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide.

Authors:  M E Wilson; R E Schifferle
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).

Authors:  P A Warmerdam; J G van de Winkel; E J Gosselin; P J Capel
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.

Authors:  J Amir; M G Scott; M H Nahm; D M Granoff
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

9.  IgG subclass-associated affinity differences of specific antibodies in humans.

Authors:  M A Persson; S E Brown; M W Steward; L Hammarström; C I Smith; C R Howard; M Wahl; B Rynnel-Dagöö; G Lefranc; A O Carbonara
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

10.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  13 in total

1.  Role of superoxide dismutase activity in the physiology of Porphyromonas gingivalis.

Authors:  M C Lynch; H K Kuramitsu
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Monocyte differentiation in localized juvenile periodontitis is skewed toward the dendritic cell phenotype.

Authors:  Suzanne E Barbour; Yuichi Ishihara; Mohammed Fakher; Salma Al-Darmaki; Timothy H Caven; C P Shelburne; Al M Best; Harvey A Schenkein; John G Tew
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  N Yamaguchi; M Kawasaki; Y Yamashita; K Nakashima; T Koga
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.

Authors:  T F Fleming; I Selmair; H Schmidt; H Karch
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations.

Authors:  Asaf Sol; Ofir Ginesin; Stella Chaushu; Laila Karra; Shunit Coppenhagen-Glazer; Isaac Ginsburg; Gilad Bachrach
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

6.  Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor.

Authors:  Y Ishihara; J B Zhang; S M Quinn; H A Schenkein; A M Best; S E Barbour; J G Tew
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Hyper-immunoglobulin G2 production by B cells from patients with localized juvenile periodontitis and its regulation by monocytes.

Authors:  J B Zhang; S M Quinn; M Rausch; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

8.  Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA.

Authors:  R C van Schie; M E Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

9.  Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Authors:  Salma Al-Darmaki; Kandi Knightshead; Yuichi Ishihara; Al Best; Harvey A Schenkein; John G Tew; Suzanne E Barbour
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Phagocytic activity of peripheral blood and crevicular phagocytes in health and periodontal disease.

Authors:  K Asif; Shaila V Kothiwale
Journal:  J Indian Soc Periodontol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.